首页 | 本学科首页   官方微博 | 高级检索  
检索        

脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响
引用本文:张树森,况时祥,肖雁,官志忠.脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响[J].中国实验方剂学杂志,2012,18(10):230-235.
作者姓名:张树森  况时祥  肖雁  官志忠
作者单位:1. 贵阳中医学院第二附属医院,贵阳,550003
2. 贵阳医学院分子生物学重点实验室,贵阳,550004
基金项目:贵州省科技攻关计划项目(黔科合SY字[2008]3048号);教育部春晖计划项目(Z2005-2-5027);贵州省中医药管理局项目(黔中医药2007020)
摘    要:目的:观察脑通胶囊对血管性痴呆(VD)大鼠学习记忆、海马N-甲基-D-天冬氨酸(NMDA)受体及锥体细胞的影响.方法:随机抽取大鼠19只作为假手术组,其余采用改良的四血管法(4-VO)制备VD模型并随机分为模型组、尼莫地平组( 12 mg·kg-1·d-1)、脑通胶囊高剂量组(1 200 mg· kg-1·d-1)、脑通胶囊中剂量组(600 mg·kg-1·d-1)、脑通胶囊低剂量组(300mg·kg-1·d-1).Morris水迷宫测定各组大鼠学习记忆能力,实时荧光定量PCR检测NMDA受体1亚基和2B亚基mRNA的表达情况,光镜观察海马CA1区锥体细胞形态及数量变化.结果:与模型组比较,脑通胶囊高、中剂量组逃避潜伏期缩短(P<0.01),穿越原平台次数增加(P<0.01,P<0.05),NMDA受体1亚基mRNA表达降低(P<0.01),2B亚基mRNA表达升高(P<0.01,P<0.05);海马CA1区锥体细胞形态未见明显病变现象,锥体细胞数量增多,锥体细胞丢失比率减少.与尼莫地平组比较,脑通胶囊高、中剂量组穿越原平台次数增加(P<0.01),NMDA受体1亚基mRNA相对表达量降低(P<0.01),高剂量组NMDA受体2B亚基mRNA相对表达量增加(P<0.05),CA1区锥体细胞增多(P<0.01).结论:脑通胶囊可降低海马NMDA受体1亚基mRNA的表达,提高2B亚基mRNA的表达,减轻海马CA1区锥体细胞损伤,减少锥体细胞丢失比率,从而改善VD大鼠学习记忆能力,这可能是其治疗VD的作用机制之一.

关 键 词:脑通胶囊  血管性痴呆  四血管法  NMDA受体  锥体细胞
收稿时间:2011/12/27 0:00:00

Effect of Naotong Capsule on the NMDA Receptors and Pyramidal Cells in Hippocampus of Vascular Dementia Model Rats
ZHANG Shu-sen,KUANG Shi-xiang,XIAO Yan and GUAN Zhi-zhong.Effect of Naotong Capsule on the NMDA Receptors and Pyramidal Cells in Hippocampus of Vascular Dementia Model Rats[J].China Journal of Experimental Traditional Medical Formulae,2012,18(10):230-235.
Authors:ZHANG Shu-sen  KUANG Shi-xiang  XIAO Yan and GUAN Zhi-zhong
Institution:The 2nd Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550003, China;The 2nd Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550003, China;Guiyang Medical College Key Molecular Biology Laboratory, Guiyang 550004, China;Guiyang Medical College Key Molecular Biology Laboratory, Guiyang 550004, China
Abstract:Objective:To observe the effects of Naotong Capsule on N-methyl-D-aspartic acid receptor(NMDA) receptors and pyramidal cells in hippocampus of vascular dementia(VD) model rats.Method:Nineteen rats were taken at random into sham group,the rest were VD models established by modified Pulsinelli 4 vascular occlusions method(4-VO) and were randomly divided into model group,nimodipine group(12 mg·kg-1·d-1),Naotong Capsule large-dose group(1 200 mg·kg-1·d-1),Naotong Capsule middle-dose group(600 mg·kg-1·d-1),and Naotong Capsule low-dose group(300 mg·kg-1·d-1).Morris water maze was used to test learning and memory abilities of rats.The mRNA expression level of NMDA receptors(subunit 1 and 2B) were determined by the Real-time Quantitative PCR.And the morphology and number of neurons in CA1 region of the hippocampus were observed by light microscope.Result:Compare to the model group,the escape time was shortened(P<0.01),times of spanning the previous platform increased(P<0.01,P<0.05),the mRNA expression level of subunit 1 decreased(P<0.01) and the mRNA expression level of subunit 2B increased(P<0.01,P<0.05),pyramidal cells showed no obvious pathogenesis and more pyramidal cells with less pyramidal cells loss rate were found in Naotong Capsule large-dose and middle-dose treatment group.Compare to the Nimodipine group,times of spanning the previous platform increased(P<0.01),the mRNA expression level of subunit 1 decreased(P<0.01) in Naotong Capsule large-dose and middle-dose treatment group,and the mRNA expression level of subunit 2B increased(P<0.05),the number of neurons in CA1 region of the hippocampus increased(P<0.01) in Naotong Capsule large-dose treatment group.Conclusion: Naotong Capsule can improve learning and memory abilities of VD rats by decreasing the mRNA expression level of subunit 1,increasing the mRNA expression level of subunit 2B of NMDA receptor and by decreasing pyramidal cells injury and loss rate in CA1 region of the hippocampus,which may be one of the therapeutic mechanisms of VD.
Keywords:Naotong capsule  vascular dementia  4 vascular occlusions  NMDA receptor  pyramidal cells
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号